318 related articles for article (PubMed ID: 16607369)
21. A functional study of purinergic signalling in the normal and pathological rabbit corpus cavernosum.
Calvert RC; Khan MA; Thompson CS; Mikhailidis DP; Burnstock G
BJU Int; 2008 Apr; 101(8):1043-7. PubMed ID: 18190636
[TBL] [Abstract][Full Text] [Related]
22. The P2Y/P2X divide: How it began.
Kennedy C
Biochem Pharmacol; 2021 May; 187():114408. PubMed ID: 33444568
[TBL] [Abstract][Full Text] [Related]
23. Agonists and Antagonists for Purinergic Receptors.
Müller CE; Baqi Y; Namasivayam V
Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
[TBL] [Abstract][Full Text] [Related]
24. Alteration of muscarinic and purinergic receptors in urinary bladder of rats with cyclophosphamide-induced interstitial cystitis.
Kageyama A; Fujino T; Taki Y; Kato Y; Nozawa Y; Ito Y; Yamada S
Neurosci Lett; 2008 May; 436(1):81-4. PubMed ID: 18372110
[TBL] [Abstract][Full Text] [Related]
25. Purinergic P2 receptors as targets for novel analgesics.
Burnstock G
Pharmacol Ther; 2006 Jun; 110(3):433-54. PubMed ID: 16226312
[TBL] [Abstract][Full Text] [Related]
26. Urinary bladder contraction and relaxation: physiology and pathophysiology.
Andersson KE; Arner A
Physiol Rev; 2004 Jul; 84(3):935-86. PubMed ID: 15269341
[TBL] [Abstract][Full Text] [Related]
27. Purinergic signalling in the urinary bladder.
Andersson KE
Auton Neurosci; 2015 Sep; 191():78-81. PubMed ID: 25979768
[TBL] [Abstract][Full Text] [Related]
28. Neural upregulation in interstitial cystitis.
Nazif O; Teichman JM; Gebhart GF
Urology; 2007 Apr; 69(4 Suppl):24-33. PubMed ID: 17462476
[TBL] [Abstract][Full Text] [Related]
29. A role for the P2X receptor in urinary tract physiology and in the pathophysiology of urinary dysfunction.
Rapp DE; Lyon MB; Bales GT; Cook SP
Eur Urol; 2005 Aug; 48(2):303-8. PubMed ID: 15963632
[TBL] [Abstract][Full Text] [Related]
30. [Gene polymorphisms in ATP (purinergic) receptors and pain sensitivity].
Ide S; Minami M; Ikeda K
Masui; 2009 Sep; 58(9):1122-9. PubMed ID: 19764435
[TBL] [Abstract][Full Text] [Related]
31. Loss of dicer exacerbates cyclophosphamide-induced bladder overactivity by enhancing purinergic signaling.
Zhang S; Lv JW; Yang P; Yu Q; Pang J; Wang Z; Guo H; Liu S; Hu J; Li J; Leng J; Huang Y; Ye Z; Wang CY
Am J Pathol; 2012 Sep; 181(3):937-46. PubMed ID: 22796409
[TBL] [Abstract][Full Text] [Related]
32. Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer.
Shabbir M; Ryten M; Thompson C; Mikhailidis D; Burnstock G
BJU Int; 2008 Feb; 101(3):352-9. PubMed ID: 18005209
[TBL] [Abstract][Full Text] [Related]
33. ATP and P2X purinoceptors in urinary tract disorders.
Ford AP; Cockayne DA
Handb Exp Pharmacol; 2011; (202):485-526. PubMed ID: 21290240
[TBL] [Abstract][Full Text] [Related]
34. Distribution of P2X(1) and P2X(3) receptors in the rat and human urinary bladder.
Elneil S; Skepper JN; Kidd EJ; Williamson JG; Ferguson DR
Pharmacology; 2001; 63(2):120-8. PubMed ID: 11490205
[TBL] [Abstract][Full Text] [Related]
35. Purinergic actions on neurons that modulate nociception in the rostral ventromedial medulla.
Selden NR; Carlson JD; Cetas J; Close LN; Heinricher MM
Neuroscience; 2007 Jun; 146(4):1808-16. PubMed ID: 17481825
[TBL] [Abstract][Full Text] [Related]
36. High-affinity, divalent ion-specific binding of 3H-ATP to homogenate derived from rabbit urinary bladder. Comparison with divalent-ion ATPase activity.
Levin RM; Jacoby R; Wein AJ
Mol Pharmacol; 1983 Jan; 23(1):1-7. PubMed ID: 6306420
[No Abstract] [Full Text] [Related]
37. Purinergic signalling underlies transforming growth factor-β-mediated bladder afferent nerve hyperexcitability.
Gonzalez EJ; Heppner TJ; Nelson MT; Vizzard MA
J Physiol; 2016 Jul; 594(13):3575-88. PubMed ID: 27006168
[TBL] [Abstract][Full Text] [Related]
38. Ion channel and receptor mechanisms of bladder afferent nerve sensitivity.
Sun B; Li Q; Dong L; Rong W
Auton Neurosci; 2010 Feb; 153(1-2):26-32. PubMed ID: 19632906
[TBL] [Abstract][Full Text] [Related]
39. Treatment-resistant detrusor overactivity--underlying pharmacology and potential mechanisms.
Andersson KE
Int J Clin Pract Suppl; 2006 Dec; (151):8-16. PubMed ID: 17169005
[TBL] [Abstract][Full Text] [Related]
40. Purinergic signalling: past, present and future.
Burnstock G
Braz J Med Biol Res; 2009 Jan; 42(1):3-8. PubMed ID: 18853040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
